Abstract:We have used homologous recombination in human embryonic stem cells (hESCs) to insert sequences encoding green fluorescent protein (GFP) into the NKX2
“…In order to generate a tool for the identification and purification of candidate human lung progenitors, we used gene editing technologies to target an enhanced green fluorescence reporter (GFP) gene to the endogenous human NKX2-1 locus in multiple human PSC lines. Prior reports of targeting GFP to the NKX2-1 locus in human PSCs for the derivation of forebrain lineages resulted in NKX2-1 haploinsufficiency (17). Hence, pursuing a strategy designed to retain intact expression of targeted loci without haploinsufficiency ( Figure 1A and Supplemental Figure 1A; supplemental material available online with this article; https:// doi.org/10.1172/JCI89950DS1), we targeted an exon3-2A-GFP cassette to the second intron of NKX2-1 using either transcription activator-like effector nucleases (TALENs) or CRISPR-Cas9 tools deployed in ESCs (H9) or in our previously published iPSC lines: cystic fibrosis patient-specific C17 iPSCs (18) and normal BU3 iPSCs ( Figure 1 and Supplemental Figure 1) (19).…”
“…In order to generate a tool for the identification and purification of candidate human lung progenitors, we used gene editing technologies to target an enhanced green fluorescence reporter (GFP) gene to the endogenous human NKX2-1 locus in multiple human PSC lines. Prior reports of targeting GFP to the NKX2-1 locus in human PSCs for the derivation of forebrain lineages resulted in NKX2-1 haploinsufficiency (17). Hence, pursuing a strategy designed to retain intact expression of targeted loci without haploinsufficiency ( Figure 1A and Supplemental Figure 1A; supplemental material available online with this article; https:// doi.org/10.1172/JCI89950DS1), we targeted an exon3-2A-GFP cassette to the second intron of NKX2-1 using either transcription activator-like effector nucleases (TALENs) or CRISPR-Cas9 tools deployed in ESCs (H9) or in our previously published iPSC lines: cystic fibrosis patient-specific C17 iPSCs (18) and normal BU3 iPSCs ( Figure 1 and Supplemental Figure 1) (19).…”
“…To gain further insight into the nature of hypothalamic patterning, we differentiated an NKX2-1:: GFP reporter cell line (Goulburn et al, 2011) to hypothalamic progenitors and immunostained for GFP and hypothalamic transcription factors. This analysis revealed that 68±5% of RAX-immunopositive cells, 15±7% of OTP-immunopositive cells and 51±16% of SIM1-immunopositive cells expressed GFP (supplementary material Fig.…”
Section: Directed Differentiation Of Hpscs Into Hypothalamic Progenitorsmentioning
Hypothalamic neurons orchestrate many essential physiological and behavioral processes via secreted neuropeptides, and are relevant to human diseases such as obesity, narcolepsy and infertility. We report the differentiation of human pluripotent stem cells into many of the major types of neuropeptidergic hypothalamic neurons, including those producing pro-opiolemelanocortin, agoutirelated peptide, hypocretin/orexin, melanin-concentrating hormone, oxytocin, arginine vasopressin, corticotropin-releasing hormone (CRH) or thyrotropin-releasing hormone. Hypothalamic neurons can be generated using a 'self-patterning' strategy that yields a broad array of cell types, or via a more reproducible directed differentiation approach. Stem cell-derived human hypothalamic neurons share characteristic morphological properties and gene expression patterns with their counterparts in vivo, and are able to integrate into the mouse brain. These neurons could form the basis of cellular models, chemical screens or cellular therapies to study and treat common human diseases.
“…Using differentiation protocols modeled after mouse studies, several laboratories have also attempted to produce MGE-like interneurons from human ESCs (Goulburn et al 2011;Germain et al 2013;Liu et al 2013a;Maroof et al 2013;Nicholas et al 2013;Kim et al 2014) and human-induced pluripotent stem cells (iPSCs) (Fig. 3) (Liu et al 2013b).…”
Section: In Vitro Sources Of Inhibitory Cortical Interneuronsmentioning
confidence: 99%
“…Three other studies have taken advantage of an hESC line, in which GFP was inserted into the Nkx2-1 locus to facilitate identification of ventral forebrain progenitors (Goulburn et al 2011;Maroof et al 2013;Nicholas et al 2013). Nkx2-1 is a homeodomain transcription factor enriched in embryonic MGE of mouse and human, as well as in thyroid, lung, and diencephalon.…”
Section: In Vitro Sources Of Inhibitory Cortical Interneuronsmentioning
Stem-cell therapy has extraordinary potential to address critical, unmet needs in the treatment of human disease. One particularly promising approach for the treatment of epilepsy is to increase inhibition in areas of the epileptic brain by grafting new inhibitory cortical interneurons. When grafted from embryos, young g-aminobutyric acid (GABA)ergic precursors disperse, functionally mature into host brain circuits as local-circuit interneurons, and can stop seizures in both genetic and acquired forms of the disease. These features make interneuron cell transplantation an attractive new approach for the treatment of intractable epilepsies, as well as other brain disorders that involve increased risk for epilepsy as a comorbidity. Here, we review recent efforts to isolate and transplant cortical interneuron precursors derived from embryonic mouse and human cell sources. We also discuss some of the important challenges that must be addressed before stem-cell-based treatment for human epilepsy is realized.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.